Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
proxy fight
Pharma
Bid to halt sales of J&J talc products rejected by shareholders
J&J will continue to sell its talc products around the world after resisting a challenge from shareholders to discontinue the practice.
Kevin Dunleavy
Apr 29, 2022 1:04pm
If aducanumab fails, Biogen could face activist investor: report
Jun 2, 2021 9:14am
Ironwood names Alex Denner to its board after R&D spinoff
Nov 9, 2020 12:27pm
FDA proposes yanking approval for AMAG Pharma's Makena
Oct 6, 2020 11:32am
Alexion's Soliris gets a reprieve with Amgen biosim settlement
Jun 1, 2020 11:31am
Activist investor blasts Alexion's $1.4B Portola buyout
May 12, 2020 1:20pm
